Clinical Trial Update: Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART) [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study focusing on optimizing metabolic management for people with HIV on integrase-based ART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections, Weight Gain | Phase 3 | Status: ACTIVE_NOT_RECRUITING